A study to assess the role of vericiguat in the cardio-pulmonary pathophysiology in worsening heart failure with reduced ejection fraction (REVOLUT- HFrEF)
10 May 2026 (12:30 - 13:15)
Organised by: 
About the speaker
Sapienza University of Rome, Rome (Italy)
5 More presentations in this session
Doctor A. Ntalianis (Athens, GR)
Doctor A. Ntalianis (Athens, GR)
Doctor S. Giovinazzo (Genoa, IT)
Doctor G. Armentaro (Catanzaro, IT)
Access the full session
The Event
Heart Failure 2026
10 May 2026
12:30 CET
You may be interested in
Congress Presentation
